搜索筛选:
搜索耗时0.0828秒,为你在为你在102,285,761篇论文里面共找到 15 篇相符的论文内容
发布年度:
[期刊论文] 作者：Xiao-Li Wei,De-Shen Wang,Shao-,
来源：世界胃肠病学杂志：英文版（电子版） 年份：2014
AIM:To explore the association between AT-rich interactive domain 1A(ARID1A)protein loss by immunohistochemistry and both clinicopathologic characteristics and...
A novel process for the recovery of iron, titanium, and vanadium from vanadium-bearing titanomagneti
[期刊论文] 作者：Ling-yun yi,Li-na Wang,De-shen,
来源：城市道桥与防洪 年份：2017
该文从挂篮荷载计算、施工流程、支座及临时固结施工、挂篮安装及试验、合拢段施工、模板制作安装、钢筋安装、混凝土的浇筑及养生、测量监控等方面人手,介绍了S226海滨大桥...
Qualitative and quantitative analysis of Tong-Feng-Li-Shi oral liquid by thin layer chromatography a
[会议论文] 作者：Lin-Li Wang,De-Shen Meng,Yi-Xin Peng,
来源：第2届大连国际色谱学术报告会、第37届国际高效液相色谱及相关技术会议、第18届全国色谱学术报告会 年份：2011
Tong-Feng-Li-Shi oral liquid, a combined prescription of traditional Chinese medicine, is prepared from medicinal herbs of Radix et Rhizoma Rhei, Fructus Crataegi and Semen vaccariae, and has been use...
Study on Toughening on Crack Prevention of Jointed Rock Masses with Different Pre-Stress Anchor Cabl
[期刊论文] 作者：WANG Zhong-chang,ZHAO De-shen,WU Hui-jun,
来源：上海交通大学学报（英文版） 年份：2012
...
Icotinib antagonizes ABCG2-mediated multidrug resistance, but not the pemetrexed resistance mediated
[会议论文] 作者：Zhe-Sheng Chen,De-Shen Wang,Dong-Hua Yang,Rui-Hua Xu,
来源：2014医学科学前沿暨第三届个体化治疗与抗肿瘤药物研究新趋向研讨会 年份：2014
ABCG2 is a potential biomarker causing multidrug resistance (MDR) in Non-Small Cell Lung Cancer (NSCLC).We conducted this study to investigate whether Icoti...
[期刊论文] 作者：徐鲁勇,张娜,匡正,ZHANG Na,LIU De-shen,
来源：中西医结合心血管病电子杂志 年份：2004
目的：评价常用两种材质过渡义齿的临床疗效，为种植修复临床工作提供参考。方法选择60例前牙种植修复患者，随机分为两组，分别制作胶连过渡义齿和隐形过渡义齿，戴用三个月，从对种植区......
[会议论文] 作者：Zhe-Sheng Chen,De-Shen Wang,Hui Zhang,Amit Tiwari,Atish Patel,Zhi Shi,
来源：2014第七届世界癌症大会 年份：2014
We found that tyrosine kinase inhibitors (TKIs) such as erlotinib, lapatinib, nilotinib, sunitinib, tandutinib, and icotinib could reverse ATP-binding cassette (ABC) transporter-mediated multidrug res...
[会议论文] 作者：Dong-dong Yang,Zhan-Hong Chen,De-Shen Wang,Yu Hong-En,Jia-Huan Lu,Rui-Hua Xu,Zhao-Lei Zeng,
来源：2019中国肿瘤学大会 年份：2019
...
,Effects of specific interleukin-1β-converting enzyme inhibitor on ischemic acute renal failure in m
[期刊论文] 作者：Hua-feng LIU,Dong LIANG,Li-ming WANG,Nan ZHOU,Cui-wei YAO,Tao HONG,De-shen TANG,Xiao-wen CHEN,
来源：中国药理学报（英文版） 年份：2005
Aim: To study the effect of selective interleukin-1 β-converting enzyme (ICE,caspase-1) inhibitor on ischemic acute renal failure (ARF). Methods: Mouse models...
[会议论文] 作者：LIU Yi,刘毅,WANG Jia-cai,汪加才,JIANG Xiao-yao,江效尧,SUNHuai-jiang,孙怀江,XIA De-shen,夏德深,
来源：第十二届中国虚拟现实大会 年份：2012
图割是图像分割中经典有效的算法，针对其计算量较大、实时性能不佳，面对广泛使用的DCT编码图像，提出一种改进的交互式快速分割算法。访算法利用DCT编码图像中的DC系数生成DC低频图像，有效降低了GMM参数学习的训练样本数，结合DC系数与AC系数生成纹理特征，通过颜色与纹......
[期刊论文] 作者：Xiao-Li Wei,De-Shen Wang,Shao-Yan Xi,Wen-Jing Wu,Dong-Liang Chen,Zhao-Lei Zeng,Rui-Yu Wang,Ya-Xin Huang,
来源：World Journal of Gastroenterology 年份：2014
AIM:To explore the association between AT-rich interactive domain 1A(ARID1A)protein loss by immunohistochemistry and both clinicopathologic characteristics and...
[期刊论文] 作者：De-Shen Wang,Ming-Tao Hu,Zhi-Qiang Wang,Chao Ren,Miao-Zhen Qiu,Hui-Yan Luo,Ying Jin,William Pat Fong,,
来源：癌症 年份：2022
背景与目的 预防化疗所致恶心呕吐在肿瘤治疗的全程管理中是十分重要的一环.本研究评价了在高危女性胃肠道肿瘤患者中,在帕洛诺司琼、地塞米松基础上联用阿瑞匹坦能否进一步预防或减轻FOLFIRI方案(氟尿嘧啶、亚叶酸和伊立替康)或FOLFOX方案(氟尿嘧啶、亚叶酸和......
[期刊论文] 作者：Yi-Yi Yu,Ming-Ming He,Kai-Yan Liu,Hui-Yan Luo,Dong-Sheng Zhang,Yin Jin,Feng-Hua Wang,Zhi-Qiang Wang,De-Shen,
来源：Chinese Journal of Cancer 年份：2015
Introduction: Right-sided colon cancer(RSCC) and left-sided colorectal cancer(LSCRC) differ with respect to their biology and genomic patterns. This study aimed...
Comparison of bevacizumab with cetuximab as the first? line bio? chemotherapy for patients with meta
[会议论文] 作者：Feng Wang,De-shen Wang,Zhao-lei Zeng,Rui-hua Xu,Zhe-zhen Li,Yun-xin Lu,Zhi-qiang Wang,Long Bai,Dong-liang,
来源：第四届广州国际肿瘤学会议 年份：2015
The present observational cohort study was designed to elucidate the efficacy and safety profile of bevacizumab or cetuximab in the first-line treatment of...
Comparison of bevacizumab with cetuximab as the first? line bio? chemotherapy for patients with meta
[会议论文] 作者：Feng Wang,Long Bai,Zhe-zhen Li,Chao Ren,Dong-sheng Zhang,Qi Zhao,De-shen Wang,Dong-liang Chen,Yun-xin,
来源：第四届广州国际肿瘤学会议 年份：2015
The present observational cohort study was designed to elucidate the efficacy and safety profile of bevacizumab or cetuximab in the first-line treatment of metastatic colorectal cancer(mCRC)in Chinese...
相关搜索：
